BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 6975160)

  • 1. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
    Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
    Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukemias].
    Ugazio AG
    Pediatr Med Chir; 1985; 7(2):177-9. PubMed ID: 2937023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological definition of leukemic cell surface phenotypes.
    Melvin SL
    Cancer Res; 1981 Nov; 41(11 Pt 2):4790-3. PubMed ID: 6975161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood.
    Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
    Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of monoclonal antibodies in the diagnosis of acute leukemia].
    Pönisch W; Friedrich T; Leiblein S; Siebert M
    Acta Histochem Suppl; 1988; 35():193-7. PubMed ID: 3138715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic cell markers in acute lymphoblastic leukemia in children].
    Grigor'iants LIa
    Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia.
    Lopez M; De Rossi G; Bonomo G; Napolitano M; Pasqualetti D; Guglielmi C; Annino L; Pandolfi F
    Diagn Immunol; 1985; 3(1):11-4. PubMed ID: 3873317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subset derivation of T-cell acute lymphoblastic leukemia in man.
    Reinherz EL; Nadler LM; Sallan SE; Schlossman SF
    J Clin Invest; 1979 Aug; 64(2):392-7. PubMed ID: 313405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia.
    Yu AL; Royston I; Leung KL; Kung FH; Hartman GA; Lightsey AL; Vangrove J; Sobol RE
    Hybridoma; 1982; 1(2):91-8. PubMed ID: 6985381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
    Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
    J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
    Babusíková O; Hrivnáková A; Cáp J; Ujházy P
    Neoplasma; 1988; 35(6):683-90. PubMed ID: 2975765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.